Fujitsu launched a new cloud-based platform that allows users to securely collect and leverage health-related data.
The new platform automatically converts medical data from medical institutions' electronic medical records to conform with the next-generation standards framework HL7 FHIR,
Consenting patients can securely store personal health information such as vital data, step counts, and calorie consumption.
These are converted into non-personally identifiable information on the platform, which supports medical institutions and pharmaceutical companies in performing data analysis and R&D activities.
The new offering represents Fujitsu’s ongoing efforts to promote digital transformation in the medical field and contribute to the creation of a healthy society.
Fujitsu will also use the platform to develop a data portability service that enables patients to view their medical data on their smartphones and allows medical institutions to conduct a highly accurate analysis of shared medical data on the platform.
Fujitsu said it aims to leverage this platform to realize an AI and IoT-based preventive healthcare system and cooperate with various medical institutions and companies to realize a digital health ecosystem.


Firelight Launches as First XRP Staking Platform on Flare, Introduces DeFi Cover Feature
Tesla Faces 19% Drop in UK Registrations as Competition Intensifies
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Asian Markets Mixed as Fed Rate Cut Bets Grow and Japan’s Nikkei Leads Gains
Trump Administration to Secure Equity Stake in Pat Gelsinger’s XLight Startup
ByteDance Unveils New AI Voice Assistant for ZTE Smartphones
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Hikvision Challenges FCC Rule Tightening Restrictions on Chinese Telecom Equipment
Intel Boosts Malaysia Operations with Additional RM860 Million Investment
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Asian Markets Stabilize as Wall Street Rebounds and Rate Concerns Ease
IKEA Expands U.S. Manufacturing Amid Rising Tariffs and Supply Chain Strategy Shift
Banks Consider $38 Billion Funding Boost for Oracle, Vantage, and OpenAI Expansion
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China 



